26.94USD-3.23%Mkt Cap: 531.20M USDP/E: 335.06Last update: 2026-06-01
Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap531.20M USD
Enterprise Value215.47M USD
Revenue (TTM)71.10M USD
Gross Profit6.28M USD
Net Income (TTM)-6.12M USD
Revenue/Share5.243 USD
Last Price26.94 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees73
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS0453961080
Valuation
P/E (Trailing)335.06
P/E (Forward)-10.21
PEG—
EV/EBITDA-16.06
EV/Revenue3.03
P/S7.71
P/B2.21
EPS (TTM)0.08
EPS (Forward)-2.71
52W Range
14.0050% of range39.71
52W High39.71 USD
52W Low14.00 USD
Profitability
Gross Margin8.84%
Oper. Margin-138.44%
EBITDA Margin-18.87%
Profit Margin-8.47%
ROE-2.96%
ROA-2.38%
Growth
Revenue Growth-12.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-41.09M USD
CapEx (TTM)66.00K USD
FCF Margin—
FCF Yield—
Net Debt-224.11M USD
Net Debt/EBITDA16.70
Balance Sheet
Debt/Equity0.01
Current Ratio6.65
Quick Ratio6.49
Book Value/Sh12.50 USD
Cash/Share14.26 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:12
Split DateFeb 12, 2024
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)48.75 USD
Target Range40.00 USD – 62.00 USD
# Analysts4
Ownership
Shares Out.19.82M
Float7.52M
Insiders28.34%
Institutions48.36%
Short Interest
Short Ratio11.8d
Short % Float14.25%
Short % Out.9.71%
Shares Short1.54M
Short (prev mo.)1.53M
Technical
SMA 5028.52 (-5.5%)
SMA 20029.00 (-7.1%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)149.63K
Avg Vol (10d)210.09K
Technical Indicators
RSI (14)47.3
MACD-0.3025
MACD Signal-0.1701
MACD Hist.-0.1325
BB Upper32.18 USD
BB Middle28.76 USD
BB Lower25.34 USD
BB Width23.81%
ATR (14)1.676 USD
Vol Ratio (20d)0.32x